MedicaidPrior AuthMedium impact
Erwinase® (asparaginase Erwinia chrysanthemi) (Revised)
Humana·OH · Oncology, Hematology·Medicaid
We identified it
Jul 21, 2026
Summary
This is a revised Prior Authorization policy for Erwinase® (asparaginase Erwinia chrysanthemi) affecting Medicaid-Ohio members. The policy update requires billing teams to verify current authorization requirements before submitting claims for this medication. Without access to the full policy content, specific changes cannot be detailed, but this fresh update (1 day old) supersedes any previous Erwinase guidance.
Action Required
Immediately: Billing team must retrieve the complete revised policy from the Humana DCTM portal (URL: https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a584858) and review all prior authorization requirements for Erwinase® (J9019). Update billing software, EMR templates, and provider communication to reflect the revised requirements. Verify that all pending and future Erwinase claims for Ohio Medicaid members comply with the new authorization criteria. Communicate changes to oncology providers and staff. Do not bill claims for Erwinase without confirming they meet current prior authorization standards.